Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Liposomal Bupivacaine vs Ropivacaine for TAP Block in Laparoscopic Gallbladder Surgery

Official title: Liposomal Bupivacaine Versus Ropivacaine for Transversus Abdominis Plane Block in Laparoscopic Cholecystectomy: A Randomized, Single-Blind, Parallel-Group Trial

Run by Tianjin First Central Hospital · NCT07577934 · Data updated 2026-11-12

In people having gallbladder removal with laparoscopy, this study tests whether liposomal bupivacaine for a TAP block reduces pain compared with standard ropivacaine.

More Postoperative Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment86 (estimated)
SponsorTianjin First Central Hospital
Academic / other
Locations1 site (Tianjin, Tianjin Municipality)
StatusRecruiting
StartedMay 10, 2026
Main results expectedJuly 1, 2026
Study endsAugust 1, 2026
Registry record updatedMay 14, 2026
Trial IDNCT07577934 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 undergoing elective laparoscopic cholecystectomy, ASA I–III, able to consent and complete 3-month follow-up.

Probably not a fit

Patients with allergies to local anesthetics or those not experiencing pain benefits may not gain a reduction in pain or quicker recovery.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized, single-blind study comparing two local anesthetic options for the transversus abdominis plane (TAP) block during laparoscopic cholecystectomy. Participants are randomly assigned to receive either liposomal bupivacaine or ropivacaine for the TAP block, with the primary outcome being the dynamic pain score at 24 hours post-surgery. Secondary outcomes include pain scores at multiple time points, recovery quality, time to first rescue analgesia, analgesic use, return of gastrointestinal function, length of hospital stay, and adverse events, plus follow-up at 3 months for chronic postsurgical pain.

Why it matters

Potential benefit: If successful, this approach could offer longer-lasting pain relief and faster recovery after gallbladder surgery.

How similar studies have gone: Other studies have explored TAP blocks with liposomal local anesthetics showing potential improved analgesia, but results vary by setting and drug.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-65 years, either gender.
* Patients scheduled for elective laparoscopic cholecystectomy.
* ASA physical status I-III.
* Able to provide written informed consent and complete the 3-month follow-up.

Exclusion Criteria:

* History of allergy to local anesthetics.
* History of dementia, psychosis, or other central nervous system diseases.
* History of chronic pain or long-term use of opioids or other analgesics.
* Contraindications to nerve block: infection at puncture site, severe coagulopathy.
* Severe hepatic or renal dysfunction, pregnancy, or lactation.

Where it's running

  • Tianjin First Central Hospital
    Tianjin, Tianjin Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.